Skip to main content
. 2022 Sep 23;12:949511. doi: 10.3389/fonc.2022.949511

Table 2.

Relationship between sarcopenia and adverse effects during conversion therapy in GC-CY1 patients.

Adverse effects Pre-treatment p Post-treatment p ΔSMI (%)/50 days p
Sarcopenia(n=7) No-sarcopenia(n=29) Sarcopenia(n=13) No-sarcopenia(n=23) SML(n=8) No-SML(n=28)
Leukopenia
Yes/No 3/4 5/24 0.167* 5/8 3/20 0.107* 6/2 2/26 <0.001*
≥3 grade/<3grade 2/5 0/29 0.033* 2/13 0/23 0.149* 2/6 0/28 0.044*
Neutropenia
Yes/No 4/3 3/26 0.016* 4/9 3/20 0.225* 5/3 2/26 0.003*
≥3 grade/<3grade 2/5 0/29 0.033* 1/12 1/22 1.000* 2/6 0/28 0.044*
Thrombocytopenia
Yes/No 3/4 1/28 0.018* 4/9 0/23 0.012* 4/4 0/28 0.001*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Decreased hemoglobin
Yes/No 1/6 0/29 0.194* 1/12 0/23 0.361* 1/7 0/28 0.222*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Nausea/vomiting
Yes/No 5/2 4/25 0.006* 5/8 4/19 0.235* 7/1 2/26 <0.001*
≥3 grade/<3grade 2/5 0/29 0.033* 1/12 1/22 1.000* 2/6 0/28 0.044*
Diarrhea
Yes/No 1/6 0/29 0.194* 1/12 0/23 0.361* 1/7 0/28 0.222*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Anorexia
Yes/No 2/5 1/28 0.090* 3/10 0/23 0.040* 3/5 0/28 0.008*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Peripheral sensory neuropathy
Yes/No 1/6 0/29 0.194* 1/12 0/23 0.361* 1/7 0/28 0.222*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
AST/ALT increased
Yes/No 0/7 1/28 1.000* 1/12 0/23 0.361* 0/8 1/27 1.000*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Proteinuria
Yes/No 2/5 2/27 0.163* 3/10 1/22 0.124* 2/6 2/26 0.207*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Oral mucositis
Yes/No 1/6 0/29 0.194* 0/13 1/22 1.000* 1/7 0/28 0.222*
≥3 grade/<3grade 0/7 0/29 1.000* 0/13 0/23 1.000* 0/8 0/28 1.000*
Fatigue
Yes/No 2/5 1/28 0.090* 3/10 0/23 0.040* 3/5 0/28 0.008*
≥3 grade/<3grade 1/6 0/29 0.194* 1/12 0/23 0.361* 1/7 0/28 0.222*

According to Common Terminology Criteria for Adverse Events (version 3.0). AST, aspartate transaminase; ALT, alanine aminotransferase. *Fisher’s exact test.